LSL Property Services Analyst Q&A: Group valuation multiples could potentially more than double (LON:LSL) 2 March 2021
Serinus Energy a material and cash generative producer with a pipeline of identified, near-term opportunities 1 March 2021
Sativa Wellness Group “shares very attractive when compared to Cellular Goods and Kanabo” 26 February 2021
KRM22 Q&A: People & Culture Risk Management initiative in partnership with Kintail Consulting (LON:KRM) 26 February 2021
MySale Group plc FY17 Finals: track record building, new opportunities and confident outlook 26 September 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
LSL Property Services Analyst Q&A: Group valuation multiples could potentially more than double (LON:LSL) 2 March 2021
Serinus Energy a material and cash generative producer with a pipeline of identified, near-term opportunities 1 March 2021
Sativa Wellness Group “shares very attractive when compared to Cellular Goods and Kanabo” 26 February 2021
KRM22 Q&A: People & Culture Risk Management initiative in partnership with Kintail Consulting (LON:KRM) 26 February 2021
MySale Group plc FY17 Finals: track record building, new opportunities and confident outlook 26 September 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Castle Biosciences (CSTL) Stock Analysis: Unpacking the Growth Potential in Molecular Diagnostics 12 December 2025
Ardelyx, Inc. (ARDX) Stock Analysis: Exploring Nearly 97% Potential Upside in Biotech 12 December 2025
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Robust Revenue Growth and Strategic Market Positioning 12 December 2025
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 304% Potential Upside in Biotech Innovation 12 December 2025
Kura Oncology, Inc. (KURA) Stock Analysis: Unveiling a 215% Potential Upside for Bold Investors 12 December 2025
Upstream Bio, Inc. (UPB) Stock Analysis: A Biotech with 71% Potential Upside Worth Watching 12 December 2025
Precigen, Inc. (PGEN) Stock Analysis: Exploring a 134% Potential Upside in Biotech Innovations 12 December 2025
Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech Contender with a 117% Revenue Growth Surge 12 December 2025
REGENXBIO Inc. (RGNX) Stock Analysis: A Promising Biotech with 129.93% Potential Upside 12 December 2025
Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unpacking the 134.88% Potential Upside 12 December 2025
Bicycle Therapeutics plc (BCYC) Stock Analysis: A Biotech with a 189% Potential Upside 12 December 2025
Intellia Therapeutics, Inc. (NTLA): Investor Outlook Reveals 134.89% Potential Upside in Gene Editing Pioneer 12 December 2025
SIGA Technologies Inc. (SIGA) Investor Outlook: Examining the Stock’s Growth Potential and Valuation Insights 12 December 2025
Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Unpacking a 130% Potential Upside in the Biotech Sector 12 December 2025
RxSight, Inc. (RXST) Stock Analysis: Examining the Market’s Reaction to the Innovative Medical Device Firm 12 December 2025
Maze Therapeutics, Inc. (MAZE) Stock Analysis: Navigating a 9.3% Potential Upside Amid Biotech Innovations 12 December 2025
Cel-Sci Corporation (CVM) Stock Analysis: A Biotech Pioneer with a 555% Upside Potential 12 December 2025
Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Promising 83.53% Upside in the Biotech Sector 12 December 2025
Strix Group confident in doubling profits after resilient trading performance (Interview) 25 March 2021
Applied Graphene Materials strong commercial progress and confidence for the future (Interview) 25 March 2021
Zotefoams show resilience and flexibility with a solid set of preliminary results (Interview) 24 March 2021
LSL Property Services Analyst Q&A: Group valuation multiples could potentially more than double (LON:LSL) 2 March 2021
Serinus Energy a material and cash generative producer with a pipeline of identified, near-term opportunities 1 March 2021
Sativa Wellness Group “shares very attractive when compared to Cellular Goods and Kanabo” 26 February 2021
KRM22 Q&A: People & Culture Risk Management initiative in partnership with Kintail Consulting (LON:KRM) 26 February 2021
MySale Group plc FY17 Finals: track record building, new opportunities and confident outlook 26 September 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
